Investigation of the Effect of Training on the Side Effects of Chemotherapy Given Via the Mobile Health Application on the Quality of Life in Colorectal Cancer Patients
NCT05940740 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70
Last updated 2025-07-14
Summary
The incidence of colorectal cancer ranks fourth worldwide after lung, prostate and breast cancers. Although chemotherapy has an important place in the treatment of colorectal cancers, it can cause side effects such as diarrhea and fatigue in patients. Cancer patients' ability to cope with treatment side effects can be benefited from technological developments. Studies have shown that mobile health applications reduce symptom experience and increase quality of life in patients with breast cancer and leukemia.
Conditions
- Colorectal Cancer
- Mobile Phone Use
- Nurse's Role
Interventions
- OTHER
-
Colorectal-Mobile application
The use of Colorectal-Mobile application by the patients on a daily basis by the researcher will be monitored remotely via the management platform of the usage status of the mobile health application.
Sponsors & Collaborators
-
Saglik Bilimleri Universitesi
collaborator OTHER -
NESLISAH YASAR KARTAL
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-03-01
- Primary Completion
- 2024-03-01
- Completion
- 2025-01-14
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Prospective Observational Trial to Evaluate Quality of Life After Neoadjuvant Radiation or Chemoradiation Followed by Surgery in Patients With Rectal Cancer
NCT03731130 ·Status: RECRUITING
-
High Dose Radiotherapy for the Treatment of Rectal Cancer
NCT03541304 ·Status: COMPLETED
-
Assessment of Efficacy of Neoadjuvant Therapy in Locally Advanced Rectal Cancer
NCT06314737 ·Status: COMPLETED
-
Short Course Radiotherapy, Unresectable Rectal Cancer, Liver Metastasis
NCT03022734 ·Status: UNKNOWN ·Phase: PHASE2
-
Effect of Silymarin in Metastatic Colorectal Cancer Patients
NCT05631041 ·Status: RECRUITING ·Phase: PHASE3
-
Can Neoadjuvant Chemoradiotherapy be Ommited in Mid-rectal Cancer
NCT06823297 ·Status: NOT_YET_RECRUITING
-
Evaluating Factors Affecting Survival in Colon and Rectum Cancer
NCT05388513 ·Status: COMPLETED
-
Preoperative Chemoradiation Versus Short Term Radiation Alone With Delayed Surgery for Stage II and III Resectable Rectal Cancer
NCT00597311 ·Status: UNKNOWN ·Phase: PHASE3
-
A Phase II Single-Arm Study of High-Bioavailability Curcumin as Neoadjuvant Chemoradiotherapy in Mid-to-Low Rectal Cancer: Integrated Clinical and Translational Analysis of Tumor Tissue
NCT07248020 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Immune Checkpoints in Predicting Response to Neoadjuvant Therapy in Rectal Cancer
NCT05457075 ·Status: COMPLETED
-
Appropriate Timing of Surgery After Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer
NCT03287843 ·Status: COMPLETED ·Phase: NA
-
FOLFOX6 Totally Neoadjuvant Chemoradiation Therapy in Locally Advanced Rectal Cancer: A Real World Study
NCT02887313 ·Status: UNKNOWN ·Phase: PHASE2
-
Additional Chemotherapy After Neoadjuvant Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer
NCT01671683 ·Status: COMPLETED
-
Intra-operative Chemotherapy With 5-FU for Colorectal Cancer Patients Receiving Curative Resection: Efficacy and Safety
NCT01465451 ·Status: UNKNOWN ·Phase: PHASE3
-
Timing for Rectal Surgery After Chemoradiotherapy
NCT03607370 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Chemoradiotherapy After Surgery Versus Preoperative Chemoradiotherapy for Stage II/III Mid-low Rectal Cancer With or Without High-risk Factors
NCT06566222 ·Status: NOT_YET_RECRUITING
-
Evaluation of Quality of Life and Utilities Following Surgical Treatment of Stage I-IV Rectal Cancer
NCT02107105 ·Status: RECRUITING
-
Disease-Specific Questionnaire in Assessing Quality of Life in Patients With Gastrointestinal-Related Neuroendocrine Tumors
NCT00454376 ·Status: UNKNOWN
-
Neoadjuvant Chemoradiotherapy Versus Neoadjuvant Chemotherapy For Unresectable Locally Advanced Colon Cancer
NCT03970694 ·Status: TERMINATED ·Phase: PHASE3
-
Neoadjuvant Chemotherapy for the Treatment of Resectable Locally Advanced Colon Cancer
NCT02882269 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Neoadjuvant Chemoradiation With Bevacizumab for Chinese Rectal Cancer Patients
NCT01554059 ·Status: COMPLETED ·Phase: PHASE2
-
Genotype-driven Phase I Study of Irinotecan Administered in Neoadjuvant Chemoradiotherapy in Patients With Stage II/III Rectal Cancer
NCT01474187 ·Status: UNKNOWN ·Phase: PHASE1
-
Chemotherapy Combined With High-dose Radiotherapy for Low Rectal Cancer Using MR Guided Linear Accelerator
NCT05338866 ·Status: ENROLLING_BY_INVITATION
-
Exploring the Predictive Effect of Intestinal and Oral Microbiota on the Efficacy of Neoadjuvant Radiotherapy and Chemotherapy for Locally Advanced Rectal Cancer Based on Machine Learning
NCT07346729 ·Status: COMPLETED
-
Neo-adjuvant Chemoradiotherapy Using Infusional Gemcitabine Followed by Surgery for Locally Advanced Rectal Cancer
NCT02919878 ·Status: UNKNOWN ·Phase: PHASE2